Immuron Limited (IMRN)

NASDAQ: IMRN · IEX Real-Time Price · USD
+0.051 (2.90%)
Feb 26, 2024, 12:09 PM EST - Market open

Immuron Revenue

Immuron had revenue of $1.24M in the twelve months ending June 30, 2023. In the fiscal year ending June 30, 2023, Immuron had annual revenue of $1.24M with 134.22% growth.

Revenue (ttm)
Revenue Growth
P/S Ratio
Revenue / Employee
Market Cap
10.61M USD

Revenue Chart

* The company reports in AUD currency but revenue data is shown in USD.


Fiscal Year End Revenue Change Growth
Jun 30, 20231.24M713.24K134.22%
Jun 30, 2022531.38K421.78K384.81%
Jun 30, 2021109.61K-1.63M-93.69%
Jun 30, 20201.74M55.66K3.31%
Jun 30, 20191.68M316.17K23.16%
Jun 30, 20181.37M291.37K27.14%
Jun 30, 20171.07M328.40K44.06%
Jun 30, 2016745.35K-27.17K-3.52%
Jun 30, 2015772.52K-151.69K-16.41%
Jun 30, 2014924.21K--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Guardion Health Sciences 12.04M
Applied DNA Sciences 9.00M
Can-Fite BioPharma 793.00K
ABVC BioPharma 739.26K
Organovo Holdings 242.00K
Oragenics 37.65K
Revenue Rankings